Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.
Takeshita S, Ichikawa T, Taura N, Miyaaki H, Matsuzaki T, Otani M, Muraoka T, Akiyama M, Miuma S, Ozawa E, Ikeda M, Kato N, Isomoto H, Takeshima F, Nakao K.
Takeshita S, et al. Among authors: muraoka t.
J Gastroenterol. 2012 Feb;47(2):195-202. doi: 10.1007/s00535-011-0481-z. Epub 2011 Oct 25.
J Gastroenterol. 2012.
PMID: 22038554